Correcting Immune Imbalance: The Use of Prosorba Column Treatment for Immune Disorders

2003 ◽  
Vol 7 (2) ◽  
pp. 197-205 ◽  
Author(s):  
Joshua Levy ◽  
Nurit Degani
2014 ◽  
Vol 21 (19) ◽  
pp. 2138-2145 ◽  
Author(s):  
X. Zhu ◽  
Z. Song ◽  
S. Zhang ◽  
A. Nanda ◽  
G. Li
Keyword(s):  

2015 ◽  
Vol 21 (19) ◽  
pp. 2643-2667 ◽  
Author(s):  
Lin Sun ◽  
Zeyu Liu ◽  
Dongmei Cun ◽  
Henry Tong ◽  
Ying Zheng

2018 ◽  
Vol 18 (5) ◽  
pp. 466-469 ◽  
Author(s):  
Stefania Cantore ◽  
Vito Crincoli ◽  
Antonio Boccaccio ◽  
Antonio E. Uva ◽  
Michele Fiorentino ◽  
...  

2021 ◽  
Vol 8 (3) ◽  
pp. 315-336
Author(s):  
Isabelle Moulonguet ◽  
Sylvie Fraitag

Panniculitides form a heterogenous group of inflammatory diseases that involve the subcutaneous adipose tissue. These disorders are rare in children and have many aetiologies. As in adults, the panniculitis can be the primary process in a systemic disorder or a secondary process that results from infection, trauma or exposure to medication. Some types of panniculitis are seen more commonly or exclusively in children, and several new entities have been described in recent years. Most types of panniculitis have the same clinical presentation (regardless of the aetiology), with tender, erythematous subcutaneous nodules. Although the patient’s age and the lesion site provide information, a histopathological assessment is sometimes required for a definitive diagnosis and classification of the disorder. In children, most panniculitides are lobular. At present, autoimmune inflammatory diseases and primary immunodeficiencies have been better characterised; panniculitis can be the presenting symptom in some of these settings. Unexplained panniculitis in a young child should prompt a detailed screen for monogenic immune disorders because the latter usually manifest themselves early in life. Here, we review forms of panniculitis that occur primarily in children, with a focus on newly described entities.


2021 ◽  
Vol 16 (1) ◽  
pp. 620-629
Author(s):  
Chenqiang Lin ◽  
Hui Zhang ◽  
Longjun Chen ◽  
Yu Fang ◽  
Jichen Chen

Abstract The purpose of this study was to investigate whether the Dictyophora echinovolvata spore polysaccharides (DESP) affect the immunity in immunocompromised mice induced by cyclophosphamide (CTX). The healthy female Kunming mice were randomly divided into six groups, including a normal control (NC) group, a positive control group, a model control (MC) group, and three groups treated with low-, intermediate-, and high-dose polysaccharide, respectively. A series of immunoregulatory properties were determined, including humoral and cellular immunity, immune function, and immune factors of mononuclear macrophages. Compared with NC and MC groups, treatment with DESP significantly increased the spleen index and decreased the thymus index; increased the serum concentrations of immunoglobulin (Ig)A, IgG, IgM, hemolysin, IL-1β, and IL-2; delayed the allergic reaction; and improved the splenic lymphocyte transformation ability; and enhanced the phagocytosis of macrophages and the ability to secrete IL-6, TNF-α, caspase-1, and NO with DESP supplementation. These results indicated that DESP might have a good regulatory effect on CTX-induced immunodeficiency in mice, adjust the body’s immune imbalance, and improve the symptoms of low immunity.


Sign in / Sign up

Export Citation Format

Share Document